Candidate gene association studies of the α4 (CHRNA4) and β2 (CHRNB2) neuronal nicotinic acetylcholine receptor subunit genes in Alzheimer's disease

Neuroscience Letters

Volumn 358, Issue 2, 2004, Pages 142-146

  Cook, Lynnette J ^a   Ho, Luk W ^a   Taylor, Alison E ^a,b   Brayne, Carol ^a   Evans, John Grimley ^c   Xuereb, John ^d   Cairns, Nigel J ^e   Pritchard, Antonia ^f   Lemmon, Helen ^g   Mann, David ^h   St Clair, David ⁱ   Turic, Dragana ^j   Hollingworth, Paul ^j   Moore, Pamela J ^j   Jehu, Luke ^j   Archer, Nicola ^k   Walter, Sarah ^k   Foy, Catherine ^k   Edmondson, Amanda ^k   Powell, John ^k   Lovestone, Simon ^k   Owen, Michael J ^j   Williams, Julie ^j   Lendon, Corinne ^f   Rubinsztein, David C ^a   more..

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c RADCLIFFE INFIRMARY   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^g ROYAL CORNHILL HOSPITAL   (United Kingdom)

^h HOPE HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY OF ABERDEEN   (United Kingdom)

^j CARDIFF UNIVERSITY   (United Kingdom)

^k KING'S COLLEGE LONDON   (United Kingdom)

more..

Author keywords

Alzheimer's disease; Genetic Association; Medical Research Council Cognitive Function and Ageing Study (MRC COGFA); Nicotinic acetylcholine receptor; Polymorphism

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA 4; NICOTINIC ACETYLCHOLINE RECEPTOR BETA 2; NICOTINIC RECEPTOR; PRESENILIN 1; PRESENILIN 2; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

AGING; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN; CELL SURVIVAL; CHOLINERGIC SYSTEM; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; GENOTYPE; HUMAN; KNOCKOUT MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION;

AGED; ALLELES; ALZHEIMER DISEASE; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; FEMALE; GENOTYPE; HUMANS; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; RECEPTORS, NICOTINIC;

EID: 12144291280     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.01.016     Document Type: Article

References (21)

1. Bartus R.T., Dean R.L. III, Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217:1982;408-417.
2. Chapman P.F., Falinska A.M., Knevett S.G., Ramsay M.F. Genes, models and Alzheimer's disease. Trends Genet. 17:2001;254-261.
3. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatric Res. 12:1975;189-198.
4. Francis P.T., Palmer A.M., Snape M., Wilcock G.K. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J. Neurol. Neurosurg. Psychiatry. 66:1999;137-147.
5. Green E., Harris J., Lambert J.-C., Mann D., Chartier-Harlin M.C., St Clair D., Lemmon H., Iwatsubo T., Lendon C. Interleukin-1 promoter polymorphisms, Ab deposition and the risk for Alzheimers disease. Neurology. 58:2002;1566-1568.
6. Guan Z.-Z., Zhang X., Ravid R., Nordberg A. Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. J. Neurochem. 74:2000;237-243.
7. Kihara T., Shimohama S., Sawada H., Kimuna J., Kume T., Kochiyama H., Maeda T., Akaike A. Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity. Ann. Neurol. 42:1997;159-163.
8. Kihana T., Shimohama S., Urushitani M., Sawada H., Kimura J., Kume T., Maeda T., Akaike A. Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity. Brain Res. 792:1998;331-334.
9. Laws S.M., Hone E., Gandy S., Martins R.N. Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J. Neurochem. 84:2003;1215-1236.
10. Martin-Ruiz C.M., Court J.A., Molnan E., Lee M., Gotti C., Mamalaki A., Tsouloufis T., Tzartos S., Ballard C., Perry R.H., Perry E.K. Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. J. Neurochem. 73:1999;1635-1640.
11. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report to the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 34:1984;939-944.
12. Narain Y., Yip A., Murphy T., Brayne C., Easton D., Grimley Evans J., Xuereb J., Cairns N., Esiri M., Furlong R.A., Rubinsztein D.C. The ACE gene and Alzheimer's disease susceptibility. J. Med. Genet. 37:2000;695-697.
13. Rubinsztein D.C., Easton D.F. Apolipoprotein E genetic variation and Alzheimer's disease. A meta-analysis. Dement. Geriatr. Cogn. Disord. 10:1999;199-209. Erratum in: Dement. Geriatr. Cogn. Disord., 11 (2000) 238.
14. Selkoe D.J. Alzheimer's disease: genes, proteins and therapy. Physiol. Rev. 81:2001;741-766.
15. Silverman M.A., Neale M.C., Sullivan P.F., Harris-Kerr C., Wormley B., Sadek H., Ma Y., Kendler K.S., Straub R.E. Haplotypes of four novel single nucleotide polymorphisms in the nicotinic acetylcholine receptor β2-subunit (CHRNB2) gene show no association with smoking initiation on nicotine dependence. Am. J. Med. Genet. 96:2000;646-653.
16. Steinlein O., Sander T., Stoodt J., Kretz R., Janz D., Prooping P. Possible association of a silent polymorphism in the neuronal nicotinic acetylcholine receptor subunit α4 with common idiopathic generalised epilepsies. Am. J. Med. Gen. 4:1997;445-449.
17. Steinlein O.K., Stoodt J., de Vos R.A.I., Jansen Steun E.N.H., Wevens A., Schutz U., Schroder H. Mutation screening of the CHRNA4 and CHRNB2 nicotinic cholinergic receptor genes in Alzheimer's disease. NeuroReport. 10:1999;2919-2922.
18. Tohgi H., Utsugisawa K., Yoshimura M., Nagene Y., Mihara M. Age-related changes in nicotinic acetylcholine receptor subunits α4 and β2 messenger RNA expression in postmortem human frontal cortex and hippocampus. Neurosci. Lett. 245:1998;139-142.
19. Warpman U., Nordberg A. Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains. NeuroReport. 6:1996;2419-2423.
20. Wevers A., Monteggia L., Nowacki S., Bloch W., Schutz U., Lindstrom J., Pereina E.F., Eisenberg H., Giacobini E., de Vos R.A., Steun E.N., Maelicke A., Albuquerque E.X., Schroder H. Expression of nicotinic acetyleholine receptor subunits in the cerebral cortex in Alzheimer's disease: histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein. Eur. J. Neurosci. 11:1999;2551-2565.
21. Zoli M., Picciotto M.R., Ferrari R., Cocchi D., Changeux J.P. Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors. EMBO J. 18:1999;1235-1244.